Molly Carr
Clinical head, Insulin Development at Eli Lilly and Company
- Role
- Associate Vice President, Insulins and Glucagon Development at Eli Lilly and Company
- Location
- Philadelphia, PA, US
- LinkedIn followers
- 500 followers
About Molly Carr
Experienced leader in business development, clinical R&D and medical affairs with a proven track record of integrating medical and commercial strategy through strong partnerships and cross-functional collaboration. Strategic thinker with the ability to drive results and influence others to move business forward with the best interests of the company and patient in mind. Experienced in Phase 1 through Phase 4 clinical trial design, medical affairs, drug file and launch planning, business development, leading teams, and working in a global environment.
Experience
Associate Vice President, Insulins and Glucagon Development
Feb 2021 — Present · Philadelphia, PA, US
Education
University of Washington
MD, Internal Medicine Residency
Columbia University Vagelos College of Physicians and Surgeons
MD, Medical degree
Barnard College
BA, Biology
University of Washington
MD, Endocrinology fellowship
Skills
- Drug Development
- Gcp
- Translational Medicine
- Therapeutic Areas
- Pharmacokinetics
- Good Clinical Practice (Gcp)
- Regulatory Submissions
- Pharmaceutical Industry
- Medical Affairs
- Regulatory Affairs
- Lifesciences
- Infectious Diseases
- Endocrinology
- Life Sciences
- Immunology
- Metabolism
- Clinical Research
- Clinical Pharmacology
- Clinical Development
- Drug Discovery
- Oncology
- Protocol
- Biostatistics
- Clinical Trials
- Diabetes
- Clinical Study Design
- Biotechnology
- Biomarkers
- Clinical
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.